Tag Archives: Part B drugs

The Rundown | Week of 8.6.2018

In this edition of The Rundown, our weekly digest of healthcare’s most important issues, we explore the cultural factors behind women’s rising risk of lung cancer, the measles outbreak in Brazil, CMS’ Part B drug pricing, and more!



Are you interested in finding out more about Privia+?